Synthesis, Characterization, and Ca2+ Antagonistic Activity of Diltiazem Metabolites

Li Rongshi, Patrick S. Farmer, Pollen K.F. Yeung, Mei Xie, Michael A. Quilliam, Stephen Pleasance, Susan E. Hewlett

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Diltiazem is a calcium antagonist widely used in the treatment of angina and hypertension. The contributions of metabolites of diltiazem to the vasorelaxant effects of diltiazem were investigated. The synthesis and spectroscopic characterization of eight major cts-diltiazem metabolites are described. Three of the compounds—N, O-didemethylated metabolite (21), O-demethylated metabolite (22), and diltiazem N-oxide (27)—have been recently reported and have not previously been synthesized. The identities of all eight synthetic metabolites have been verified with samples obtained from human urine using combined LC-MS/MS. The Ca2+ antagonistic activities of diltiazem and its metabolites (except 27) were studied on hamster arota preparations depolarized with KCl. The order of potencies (IC50 ± SE, μ M) is as follows: diltiazem (0.98 ± 0.47) > 17 (2.46 ± 0.38) ≥ 23 (3.27 ± 1.02) > 26 (20.2 ± 10.5) 22 (40.4 ± 15.4) > 25 (45.5 ± 18.1) > 21 (112.2 ± 33.2) ≥ 24 (126.7 ± 24.2). Structure-activity relationships are also discussed.

Original languageEnglish (US)
Pages (from-to)3246-3253
Number of pages8
JournalJournal of Medicinal Chemistry
Volume35
Issue number17
DOIs
StatePublished - Aug 1 1992

Fingerprint

Diltiazem
Structure-Activity Relationship
Vasodilator Agents
Cricetinae
Oxides
Inhibitory Concentration 50
Urine
Hypertension
Calcium

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Rongshi, L., Farmer, P. S., Yeung, P. K. F., Xie, M., Quilliam, M. A., Pleasance, S., & Hewlett, S. E. (1992). Synthesis, Characterization, and Ca2+ Antagonistic Activity of Diltiazem Metabolites. Journal of Medicinal Chemistry, 35(17), 3246-3253. https://doi.org/10.1021/jm00095a022

Synthesis, Characterization, and Ca2+ Antagonistic Activity of Diltiazem Metabolites. / Rongshi, Li; Farmer, Patrick S.; Yeung, Pollen K.F.; Xie, Mei; Quilliam, Michael A.; Pleasance, Stephen; Hewlett, Susan E.

In: Journal of Medicinal Chemistry, Vol. 35, No. 17, 01.08.1992, p. 3246-3253.

Research output: Contribution to journalArticle

Rongshi, L, Farmer, PS, Yeung, PKF, Xie, M, Quilliam, MA, Pleasance, S & Hewlett, SE 1992, 'Synthesis, Characterization, and Ca2+ Antagonistic Activity of Diltiazem Metabolites', Journal of Medicinal Chemistry, vol. 35, no. 17, pp. 3246-3253. https://doi.org/10.1021/jm00095a022
Rongshi, Li ; Farmer, Patrick S. ; Yeung, Pollen K.F. ; Xie, Mei ; Quilliam, Michael A. ; Pleasance, Stephen ; Hewlett, Susan E. / Synthesis, Characterization, and Ca2+ Antagonistic Activity of Diltiazem Metabolites. In: Journal of Medicinal Chemistry. 1992 ; Vol. 35, No. 17. pp. 3246-3253.
@article{85d0669eded2402997b96f9d8b861feb,
title = "Synthesis, Characterization, and Ca2+ Antagonistic Activity of Diltiazem Metabolites",
abstract = "Diltiazem is a calcium antagonist widely used in the treatment of angina and hypertension. The contributions of metabolites of diltiazem to the vasorelaxant effects of diltiazem were investigated. The synthesis and spectroscopic characterization of eight major cts-diltiazem metabolites are described. Three of the compounds—N, O-didemethylated metabolite (21), O-demethylated metabolite (22), and diltiazem N-oxide (27)—have been recently reported and have not previously been synthesized. The identities of all eight synthetic metabolites have been verified with samples obtained from human urine using combined LC-MS/MS. The Ca2+ antagonistic activities of diltiazem and its metabolites (except 27) were studied on hamster arota preparations depolarized with KCl. The order of potencies (IC50 ± SE, μ M) is as follows: diltiazem (0.98 ± 0.47) > 17 (2.46 ± 0.38) ≥ 23 (3.27 ± 1.02) > 26 (20.2 ± 10.5) 22 (40.4 ± 15.4) > 25 (45.5 ± 18.1) > 21 (112.2 ± 33.2) ≥ 24 (126.7 ± 24.2). Structure-activity relationships are also discussed.",
author = "Li Rongshi and Farmer, {Patrick S.} and Yeung, {Pollen K.F.} and Mei Xie and Quilliam, {Michael A.} and Stephen Pleasance and Hewlett, {Susan E.}",
year = "1992",
month = "8",
day = "1",
doi = "10.1021/jm00095a022",
language = "English (US)",
volume = "35",
pages = "3246--3253",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "17",

}

TY - JOUR

T1 - Synthesis, Characterization, and Ca2+ Antagonistic Activity of Diltiazem Metabolites

AU - Rongshi, Li

AU - Farmer, Patrick S.

AU - Yeung, Pollen K.F.

AU - Xie, Mei

AU - Quilliam, Michael A.

AU - Pleasance, Stephen

AU - Hewlett, Susan E.

PY - 1992/8/1

Y1 - 1992/8/1

N2 - Diltiazem is a calcium antagonist widely used in the treatment of angina and hypertension. The contributions of metabolites of diltiazem to the vasorelaxant effects of diltiazem were investigated. The synthesis and spectroscopic characterization of eight major cts-diltiazem metabolites are described. Three of the compounds—N, O-didemethylated metabolite (21), O-demethylated metabolite (22), and diltiazem N-oxide (27)—have been recently reported and have not previously been synthesized. The identities of all eight synthetic metabolites have been verified with samples obtained from human urine using combined LC-MS/MS. The Ca2+ antagonistic activities of diltiazem and its metabolites (except 27) were studied on hamster arota preparations depolarized with KCl. The order of potencies (IC50 ± SE, μ M) is as follows: diltiazem (0.98 ± 0.47) > 17 (2.46 ± 0.38) ≥ 23 (3.27 ± 1.02) > 26 (20.2 ± 10.5) 22 (40.4 ± 15.4) > 25 (45.5 ± 18.1) > 21 (112.2 ± 33.2) ≥ 24 (126.7 ± 24.2). Structure-activity relationships are also discussed.

AB - Diltiazem is a calcium antagonist widely used in the treatment of angina and hypertension. The contributions of metabolites of diltiazem to the vasorelaxant effects of diltiazem were investigated. The synthesis and spectroscopic characterization of eight major cts-diltiazem metabolites are described. Three of the compounds—N, O-didemethylated metabolite (21), O-demethylated metabolite (22), and diltiazem N-oxide (27)—have been recently reported and have not previously been synthesized. The identities of all eight synthetic metabolites have been verified with samples obtained from human urine using combined LC-MS/MS. The Ca2+ antagonistic activities of diltiazem and its metabolites (except 27) were studied on hamster arota preparations depolarized with KCl. The order of potencies (IC50 ± SE, μ M) is as follows: diltiazem (0.98 ± 0.47) > 17 (2.46 ± 0.38) ≥ 23 (3.27 ± 1.02) > 26 (20.2 ± 10.5) 22 (40.4 ± 15.4) > 25 (45.5 ± 18.1) > 21 (112.2 ± 33.2) ≥ 24 (126.7 ± 24.2). Structure-activity relationships are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026611863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026611863&partnerID=8YFLogxK

U2 - 10.1021/jm00095a022

DO - 10.1021/jm00095a022

M3 - Article

C2 - 1507210

AN - SCOPUS:0026611863

VL - 35

SP - 3246

EP - 3253

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 17

ER -